GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fuan Pharmaceutical (Group) Co Ltd (SZSE:300194) » Definitions » Operating Margin %

Fuan Pharmaceutical (Group) Co (SZSE:300194) Operating Margin % : 15.26% (As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Fuan Pharmaceutical (Group) Co Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Fuan Pharmaceutical (Group) Co's Operating Income for the three months ended in Sep. 2024 was ¥86 Mil. Fuan Pharmaceutical (Group) Co's Revenue for the three months ended in Sep. 2024 was ¥562 Mil. Therefore, Fuan Pharmaceutical (Group) Co's Operating Margin % for the quarter that ended in Sep. 2024 was 15.26%.

Warning Sign:

Fuan Pharmaceutical (Group) Co Ltd operating margin has been in a 5-year decline. The average rate of decline per year is -5.1%.

The historical rank and industry rank for Fuan Pharmaceutical (Group) Co's Operating Margin % or its related term are showing as below:

SZSE:300194' s Operating Margin % Range Over the Past 10 Years
Min: 6.68   Med: 9.36   Max: 20.2
Current: 11.48


SZSE:300194's Operating Margin % is ranked better than
63.17% of 983 companies
in the Drug Manufacturers industry
Industry Median: 6.96 vs SZSE:300194: 11.48

Fuan Pharmaceutical (Group) Co's 5-Year Average Operating Margin % Growth Rate was -5.10% per year.

Fuan Pharmaceutical (Group) Co's Operating Income for the three months ended in Sep. 2024 was ¥86 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Sep. 2024 was ¥305 Mil.


Fuan Pharmaceutical (Group) Co Operating Margin % Historical Data

The historical data trend for Fuan Pharmaceutical (Group) Co's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fuan Pharmaceutical (Group) Co Operating Margin % Chart

Fuan Pharmaceutical (Group) Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.94 8.35 7.81 6.68 9.04

Fuan Pharmaceutical (Group) Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.93 1.63 15.12 13.87 15.26

Competitive Comparison of Fuan Pharmaceutical (Group) Co's Operating Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Fuan Pharmaceutical (Group) Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fuan Pharmaceutical (Group) Co's Operating Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fuan Pharmaceutical (Group) Co's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Fuan Pharmaceutical (Group) Co's Operating Margin % falls into.


;
;

Fuan Pharmaceutical (Group) Co Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Fuan Pharmaceutical (Group) Co's Operating Margin % for the fiscal year that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=239.418 / 2647.753
=9.04 %

Fuan Pharmaceutical (Group) Co's Operating Margin % for the quarter that ended in Sep. 2024 is calculated as

Operating Margin %=Operating Income (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=85.812 / 562.27
=15.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fuan Pharmaceutical (Group) Co  (SZSE:300194) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Fuan Pharmaceutical (Group) Co Operating Margin % Related Terms

Thank you for viewing the detailed overview of Fuan Pharmaceutical (Group) Co's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Fuan Pharmaceutical (Group) Co Business Description

Traded in Other Exchanges
N/A
Address
No.1 Huanan 1 Road, Changshou District, Chongqing, CHN, 401254
Fuan Pharmaceutical (Group) Co Ltd is mainly engaged in the production and sales of bulk drugs and preparations. The company mainly deals with anti-infective, anti-tumor, mental nervous system, cardiovascular and cerebrovascular, digestive system, endocrine and metabolic, bone and muscle systems. Its products include penicillin and cephalosporins.
Executives
Wu Xiong Hui Executives
Huang Tao Directors, executives
Feng Jing Executives
Yu Xue Song Directors, executives
Hong Rong Chuan Executives
Tang Qin Secretary, Director
Wang Tian Xiang Director
Sun Yong Ping Executives
Jiang Chen Directors, executives
Huang Dao Fei Supervisors
Wen Min Director
Zhou Xu Dong Executives
Zhou Zhong Sheng Supervisors

Fuan Pharmaceutical (Group) Co Headlines

No Headlines